A
Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body; 4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Catenae Innovation PLC (AIM: CTEA), the AIM quoted provider of digital media and technology, announces that, further to the announcement made by the Company on 16 October 2020, it has renamed its 50/50 Joint Venture Company to Synovate Global Limited ( Synovate ) and Synovate has received its first orders.
Synovate is a joint venture between Catenae and BHA-Medical ( BHA ) in which Catenae licenses its technology platforms and BHA provides its Covid-19 CE-certified and scientifically validated by the UK Government Near-Patient Healgen Antigen test and its Covid-19 CE-certified Near-Patient Antai Triple-Antibody test.
Through Synovate, BHA has provided badminton s national governing body - Badminton England with its Near-Patient Healgen Antigen test kits, and Catenae has supplied its GDPR-compliant data management platform, for the Badminton Europe Qualification Group 1 matches that took place in Milton Keynes between 9 - 12 December 2020.